Gut Microbiotas, Plasma Metabolites, and Autism Spectrum Disorder: A Bidirectional Mendelian Randomization Analysis
Pathogens · 10.11.2025 · 14 (11) · 1137
DOI: 10.3390/pathogens14111137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 10.11.2025. Verfasst von Jiayi Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Tomas Lindahl Nobel Laureate Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Autism Spectrum Disorder. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Previous studies have indicated that the gut microbiome and plasma metabolites play key roles in autism spectrum disorder (ASD), but their causal relationships remain unclear. Linkage disequilibrium score regression (LDSC) and Mendelian randomization (MR) are powerful tools for assessing genetic causality. This study uses LDSC and MR to investigate the genetic links between the gut microbiome and ASD and explore the mediating role of plasma metabolites.
Methods
To explore the genetic relationships between the gut microbiome, plasma metabolites, and ASD, we obtained summary statistics from large-scale genome-wide association studies (GWAS). Gut microbiome data came from a MiBioGen consortium meta-analysis (N = 18,340), ASD data from the Danish Psychiatric Central Research Register (DPCRR) (N = 18,382), and plasma metabolite data from the Canadian Longitudinal Study of Aging (CLSA) (N = 8299). We applied LDSC and bidirectional MR to analyze the genetic associations between the gut microbiome and ASD and plasma metabolites and ASD. Mediation MR was used to assess the mediating role of plasma metabolites in the gut microbiome-ASD relationship.
Results
LDSC analysis revealed significant genetic correlations between the gut microbiota Lachnospiraceae NK4A136 group and Sellimonas with ASD. Moreover, bidirectional MR demonstrated causal effects of five gut microbial genera on ASD risk, as indicated by inverse variance weighted (IVW) methods. Similarly, we identified 49 plasma metabolites that exhibited genetic correlations with ASD, and 58 metabolites had causal effects on ASD in MR analysis. Mediation analysis revealed that specific bacteria, Ruminiclostridium5, reduce the occurrence of ASD through metabolites Delta-CEHC and Docosadioate (C22-DC). Furthermore, Ruminococcaceae UCG005 and Sutterella modulate ASD by inhibiting Serotonin and N-acetyl-L-glutamine, respectively.
Conclusions
This study provides evidence of a causal relationship between the gut microbiome and ASD, with plasma metabolites acting as a potential mediator. Our findings offer new insights into the causal mechanisms linking the gut microbiome and ASD and provide a theoretical foundation for microbiome-based therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tomas Lindahl Nobel Laureate Laboratory, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
- Department of Geriatrics, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
- Department of Otolaryngology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
- Inner Mongolia Key Laboratory of Allergic Diseases, Foundational and Translational Medical Research Center, Hohhot First Hospital, Hohhot 010030, China.
- Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
- Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
ORCID-Profile: Jiayi Zhou, Zhang Fu, Caiyan An, Ningning Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, J., Fu, Z., Gao, Y., An, C., Zhang, Z., Zhong, X., Tian, L., Yang, X., Zhang, J., Zhang, Q., Wang, D., & Li, N. (2025). Gut Microbiotas, Plasma Metabolites, and Autism Spectrum Disorder: A Bidirectional Mendelian Randomization Analysis. Pathogens, 14(11), 1137. https://doi.org/10.3390/pathogens14111137
Vancouver
Zhou J, Fu Z, Gao Y, An C, Zhang Z, Zhong X, et al. Gut Microbiotas, Plasma Metabolites, and Autism Spectrum Disorder: A Bidirectional Mendelian Randomization Analysis. Pathogens. 2025;14(11):1137. doi:10.3390/pathogens14111137
BibTeX
@article{Zhou2025,
author = {Zhou, Jiayi and Fu, Zhang and Gao, Yunfei and An, Caiyan and Zhang, Zhiqiang and Zhong, Xin and Tian, Liusuyan and Yang, Xiuyan and Zhang, Junjing and Zhang, Qingyuan and Wang, Dilong and Li, Ningning},
title = {Gut Microbiotas, Plasma Metabolites, and Autism Spectrum Disorder: A Bidirectional Mendelian Randomization Analysis},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {11},
pages = {1137},
doi = {10.3390/pathogens14111137}
}
EUVIMED